Terms: = Colorectal cancer AND SPOP, TEF2, 8405, ENSG00000121067, O43791 AND Treatment
6 results:
1. TMEM160 promotes tumor immune evasion and radiotherapy resistance via PD-L1 binding in colorectal cancer.
Dai X; Wu Z; Ruan R; Chen J; Huang C; Lei W; Yao Y; Li L; Tang X; Xiong J; Feng M; Deng J
Cell Commun Signal; 2024 Mar; 22(1):168. PubMed ID: 38454413
[TBL] [Abstract] [Full Text] [Related]
2. CSN6-spop-HMGCS1 Axis Promotes Hepatocellular Carcinoma Progression via YAP1 Activation.
Li K; Zhang J; Lyu H; Yang J; Wei W; Wang Y; Luo H; Zhang Y; Jiang X; Yi H; Wang M; Zhang C; Wu K; Xiao L; Wen W; Xu H; Li G; Wan Y; Yang F; Yang R; Fu X; Qin B; Zhou Z; Zhang H; Lee MH
Adv Sci (Weinh); 2024 Apr; 11(14):e2306827. PubMed ID: 38308184
[TBL] [Abstract] [Full Text] [Related]
3. Clinical significance of spop and APC gene alterations in colorectal cancer in Indian population.
Ali A; Nimisha ; Sharma AK; Mishra PK; Saluja SS
Mol Genet Genomics; 2023 Sep; 298(5):1087-1105. PubMed ID: 37289229
[TBL] [Abstract] [Full Text] [Related]
4. BET Inhibitors Potentiate Chemotherapy and Killing of
Tan X; Tong J; Wang YJ; Fletcher R; Schoen RE; Yu J; Shen L; Zhang L
Cancer Res; 2019 Mar; 79(6):1191-1203. PubMed ID: 30674532
[TBL] [Abstract] [Full Text] [Related]
5. Relationship between spop mutation and breast cancer in Chinese population.
Khan MA; Zhu L; Tania M; Xiao XL; Fu JJ
Genet Mol Res; 2015 Oct; 14(4):12362-6. PubMed ID: 26505385
[TBL] [Abstract] [Full Text] [Related]
6. [Inhibitory effect and mechanism of (-)-epigallocatechin-3-gallate on HT29 and HCT-8 colorectal cancer cell lines and expression of HES1 and JAG1].
Zhang CX; Wang SM; Jin HY
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Aug; 14(8):636-9. PubMed ID: 21866461
[TBL] [Abstract] [Full Text] [Related]
